ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

1α-ヒドロキシコレカルシフェロール

Alfacalcidol

HCID 5282181
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
41294-56-8
標準SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
InChIKey
OFHCOWSQAMBJIW-AVJTYSNKSA-N
分子式
C27H44O2
平均分子量
400.6 g/mol
単同位体質量
400.33413065

概要

Alfacalcidol is a member of the class of D3 vitamins that is calciol in which the hydrogen at the 1alpha position is replaced by a hydroxy group. It is an active metabolite of cholecalciferol, which performs important functions in regulation of the calcium balance and the bone metabolism. It has a role as a bone density conservation agent. It is a diol, a seco-cholestane, a hydroxycalciol and a member of D3 vitamins. It is functionally related to a calciol.

名称と識別子

優先名称
Alfacalcidol
IUPAC
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
現地名
1α-ヒドロキシコレカルシフェロール
英語名
Alfacalcidol
分子式
C27H44O2
分子量
400.64

名称と別名

alfacalcidol41294-56-81-HydroxycholecalciferolAlphacalcidol1alpha-Hydroxyvitamin D3AlfarolEinsAlpha1-Hydroxyvitamin D31alpha-HydroxycholecalciferolAlsiodolOxydevitBondiol
名称をさらに表示
トヨファロールエルシボンビタミロアルファ1α-ヒドロキシビタミンD3アルファカルシドールポロセーブ1-ヒドロキシビタミンD3ワンアルファワン-アルファプラチビットカルシタミンカルフィーナ1α-ヒドロキシコレカルシフェロール1-ヒドロキシコレカルシフェロールアルシオドールアルファD3アロートールアルファスリー(5Z,7E)-9,10-セココレスタ-5,7,10(19)-トリエン-1α,3β-ジオールアルカドールHYDROXYVITAMIN D3Alfacalcidiol1α-Hydroxyvitamin D3EtαUn Alfa
alpha-CalcidolOne-AlphaEtalphaAlfacalcidolumAlpha D3AlpharolTevabone1alpha-Hydroxy-vitamin D3

物性

構造計算による物性補完中

XLogP
6.8
極性表面積
40.5 Ų
水素結合供与体数
2
水素結合受容体数
2
回転可能結合数
6
重原子数
29
形式電荷
0
複雑度
643

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LipidsLipids -> Sterol Lipids [ST] -> Secosteroids [ST03] -> Vitamin D3 and derivatives [ST0302]
Solubility · 2 件

<1 mg/mL

1.63e-03 g/L

Melting Point136 °C
Physical DescriptionSolid

物理化学的性質

融点
134 · 134-136°C
沸点
531.5 · 531.5±50.0 °C(Predicted)
比重(密度)
1.01 · 1.01±0.1 g/cm3(Predicted)
貯蔵温度
20 °C · −20°C
溶解性
96 · 水にほとんど溶けず、エタノールに溶けやすく(96%)、脂肪油に溶けます。
外見
白色結晶性固体
酸解離定数(Pka)
14.43 · 14.43±0.40(Predicted)
色
White to Almost white
由来生物
synthetic
Merck
14 · 14,4819

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P260, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P316, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 48 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationAlfacalcidol: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesAcute Tox. 2 (100%)

毒性情報

Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Alfacalcidol

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

安全データ

F
8-10
wgk
3
rtecs
VS2851000
ridadr
UN 2811 6.1/PG 1
hs_code
29361000
risk_code
26/27/28-36/37/38
hazard_code
T+,Xi
safety_code
28-36/37-45-36-26
hazard_class

化学と産業

薬理情報

ATC Code · 3 件

A11CC03

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingThe active metabolite of alfacalcidol, 1,25-dihydroxyvitamin D, is transported to tissues via globulin, a specific transport protein.
Pharmacodynamics · 1 件

Alfacalcidol works to increase serum levels of calcium by stimulating intestinal calcium absorption, reabsorption of calcium from bone, and possibly the renal reabsorption of calcium. It also modestly promotes intestinal phosphorus absorption. In patients with renal failure, alfacalcidol increased intestinal calcium and phosphorus absorption in a dose-related manner. This increase in calcium and phosphorus levels occurs within three days following drug administration: this effect was reversed within three days of drug discontinuation. In patients with chronic renal failure, serum calcium levels were elevated while parathyroid hormone and alkaline phosphatase levels returned to normal levels within five days following alfacalcidol administration. Since alfacalcidol suppresses parathyroid hormone, a reduction in parathyroid hormone levels is achieved more rapidly in patients on intermittent intravenous therapy, with significant reductions occurring within three months of therapy. In patients receiving daily oral therapy of alfacalcidol, the time it takes alfacalcidol to normalize plasma calcium levels may be up to several months, possibly reflecting calcium being utilized for bone mineralization. In patients with nutritional osteomalacia, alfacalcidol increased calcium absorption with six hours of oral administration and the effects peaked at 24 hours.

Mechanism of Action · 1 件

In conditions like chronic renal failure, renal bone disease, hypoparathyroidism, and vitamin D dependent rickets, the kidneys' capacity for 1α-hydroxylation is impaired, leading to reduced production of endogenous 1,25-dihydroxyvitamin D and aberrated mineral metabolism. As an active and potent analog of vitamin D, alfacalcidol works to restore the functions and activities of endogenous 1,25-dihydroxyvitamin D.

Biological Half-LifeThe half-life of alfacalcidol ranges from three to four hours.

関連反応

5 件
反応記録を作成
HRID 348784 の反応式
HRID 348784生成物として
HRID 553331 の反応式
HRID 553331生成物として
HRID 1758905 の反応式
HRID 1758905反応物として
HRID 2259556 の反応式
HRID 2259556反応物として
HRID 2259557 の反応式
HRID 2259557反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
41294-56-8
PubChem CID
5282181
DTXSID
DTXSID0022569
ChEMBL
CHEMBL1601669
ChEBI
CHEBI:31186
UNII
URQ2517572
EC Number
255-297-1
Nikkaji
J9.282G
安定性
Light Sensitive
InChIKey
OFHCOWSQAMBJIW-GITLSTMWSA-N
SMILES
[C@@H]1(O)CC(=C/C=C2\CCC[C@@]3(C)[C@@]\2([H])CC[C@@H]3[C@H](C)CCCC(C)C)C(=C)[C@H](O)C1
CAS データベース
41294 · 41294-56-8(CAS DataBase Reference)
EPAの化学物質情報
Alphacalcidol (41294-56-8)

化学的性質

化学的特性White Solid

6.1(a)
packing_group
I
Hazard Classifications
Acute Tox. 1 Oral
ストレージクラス
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
Metabolism/Metabolites · 1 件

Alfacalcidol is rapidly converted in the liver to 1,25-dihydroxyvitamin D, which is essentially the metabolite of vitamin D that regulates calcium and phosphate metabolism. Alfacalcidol is further metabolized to other polar inactive metabolites, excreted primarily through the bile.

MeSH Pharmacological ClassificationAgents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.
Absorption, Distribution and ExcretionAlfacalcidol is absorbed passively and almost completely in the small intestine.
Cellular LocationsCytoplasm
応用分野 · 3 件

用途活性型ビタミンD誘導体骨代謝を改善する基礎治療薬

使用A synthetic analog of Calcitiol (the hormonal form of vitamin D3), which shows identical potency with respect to stimulation of intestinal calcium absorption and bone mineral mobilization. Vitamin D source

一般的な説明Has biological properties similar to 1α-Hydroxyvitamin D2 (Cat. No. 679100). Converted to active Calcitriol (1α,25-Dihydroxyvitamin D3; Cat. No. 679101) in vivo. Inhibits the formation of nephrocalcinosis in streptozotocin-induced diabetic rats fed on low zinc diets.

上流・下流製品情報

上流原料

水素化リチウムアルミニウム3-クロロ過安息香酸ポロキサミン11011,2,3,6-テトラヒドロ-4-フェニルピリジン 塩酸塩
補足説明 · 1 件

定義ChEBI: A member of the class of D3 vitamins that is calciol in which the hydrogen at the 1alpha position is replaced by a hydroxy group. It is an active metabolite of cholecalciferol, which performs important functions in reg lation of the calcium balance and the bone metabolism.